Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech and Artus in Marketing Pact

NEW YORK, July 7 (GenomeWeb News) - MWG Biotech and Artus today announced a co-marketing agreement to distribute ExpressArt, an mRNA amplification kit for all platforms used microarray analysis.

 

Financial details of the agreement were not disclosed. The product will be available from MWG in September, the company said in a statement. MWG will also offer the product as part of its hybridization services business, but limiting samples accepted to a minimum of 100 nanograms of total RNA.

 

MWG, and Artus will also continue to collaborate to develop an automated mRNA amplification kit for use on Theonyx, MWG's lab automation platform for microarray experimentation.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.